Trials / Completed
CompletedNCT02725099
Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
Chewing Versus Traditional Oral Administration of Ticagrelor in ST-elevation Myocardial Infarction Patients - A Platelet Reactivity Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To examine chewing versus traditional oral administration of ticagrelor in ST-elevation Myocardial Infarction (STEMI) patients on platelet reactivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chewing Ticagrelor | 180 mg Chewing Ticagrelor |
| DRUG | Oral Ticagrelor | 180 mg oral Ticagrelor |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-03-31
- Last updated
- 2017-01-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02725099. Inclusion in this directory is not an endorsement.